Pentoxifylline, Cisplatin, Nephrotoxixcity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pentoxifylline, Cisplatin, Nephrotoxixcity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT05640817

Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) encompasses a variety of tumors originating in the lip, oral cavity, hypopharynx, oropharynx, nasopharynx and lary…

Egypt90 participantsStarted 2023-01-10

Treatment: Pentoxifylline 400 mg SR tablets, cisplatin with standard hydration with normal saline